Refine by
Drug Monitoring Articles & Analysis
18 articles found
The MDCK permeability assay is a critical technique employed in pharmacology and drug development to evaluate the permeability of drug candidates across epithelial cell layers. ...
Peptide drugs are bioactive protein fragments composed of short chains of amino acids. ...
Enzyme-linked immunosorbent assay (ELISA) has traditionally been used to monitor the total content of HCP in the production of therapeutic protein drugs. ...
These models can be used to study disease progression, test drug candidates, and gain insights into drug mechanisms of action. ...
Introduction Genomics has revolutionized cancer research, transforming the way we diagnose, treat, and monitor cancer. Among the powerful genetic analysis methods, Whole Exome Sequencing (WES) stands out as a cutting-edge technique that employs sequence capture technology to enrich DNA from the whole exome regions, enabling high-throughput sequencing. ...
Advantages of Single-Cell RNA Sequencing in Drug Discovery Single-Cell RNA Sequencing (scRNA-seq) offers several advantages in drug discovery, primarily through target identification. ...
As a leading innovator and disruptive drug delivery company, SmartTab is driving the future of drug delivery to places people would have never expected it to go and injections with a conventional syringe and needle will soon be a thing of the past. ...
BySmartTab
SmartTab is pioneering a wireless remote controlled drug delivery system, has completed pre-clinical animal studies and is preparing for human clinical trials for its core technology TargetTab™. ...
BySmartTab
Predicting and developing novel drug targets and biomarkers by cancer bioinformatics improves the speed and targeting ability of new therapies and drug development. ...
In a pioneering “off-the-shelf ” drug treatment in place of a surgical procedure, Maruti Hospital on Tuesday inaugurated its Regenerative Medicine Department by administering stem cell therapy for a diabetic patient who lost four toes on both feet. ...
Keeping a patient’s information together can also help with discussing drug interactions and other possible issues. As this information is shared with other pharmacy databases, an overall picture can become available to the physician who works most closely with the patient. ...
Multiplex real-time PCR: A guide to application In multiplex real-time PCR (qPCR), scientists amplify two or more target genes in the same reaction, using the same reagent mix. Multiplexing allows scientists to overcome limitations for myriad applications. First and foremost, multiplexing enables scientists to conserve valuable samples used in a quantitative assay, which is especially ...
For instance, in the United States, the Food and Drug Administration (FDA) carefully monitors pharmaceutical companies to ensure they are complying with the FDA’s Current Good Manufacturing Practice regulations. ...
Drug Storage Monitoring Protect your drug cabinets and refrigerators Temperature and Humidity Wireless Sensors Access Control Drug storage monitoring is essential for maintaining secure storage and control over restricted substances. ...
ByAKCP
The updated document sets a milestone for adjustments needed within European agencies overseeing regulatory applications of drug products, and environmental monitoring in sterile manufacturing. ...
Their collaboration has the potential to impact disease monitoring and drug development for cancer, metabolic disorders, neurodegeneration, aging and aging-related pathologies. ...
It is imperative that effective monitoring and treatment options be available to patients. Nanotechnology is a focal point in diabetes research, where nanoparticles in particular are showing great promise in improving the treatment and management of the disease. Due to their ability to potentially enhance drug delivery to areas where there are barriers or ...
While tracking systems have been developed to decrease occurrences and consequences of medication errors in healthcare facilities, there is a growing need for similar systems to monitor drugs that have just entered the market with unknown adverse events. Between 1997 and 2005, the FDA's MedWatch system successfully identified 15 drugs with toxic ...